Your browser doesn't support javascript.
loading
Deciphering Binding Interactions of IL-23R with HDX-MS: Mapping Protein and Macrocyclic Dodecapeptide Ligands.
Sayago, Cristina; Gonzalez Valcarcel, Isabel C; Qian, Yuewei; Lee, John; Alsina-Fernandez, Jorge; Fite, Nathan C; Carrillo, Juan J; Zhang, Feiyu F; Chalmers, Michael J; Dodge, Jeffrey A; Broughton, Howard; Espada, Alfonso.
Afiliação
  • Sayago C; Centro de Investigación Lilly S.A., 28108-Alcobendas, Spain.
  • Gonzalez Valcarcel IC; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.
  • Qian Y; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.
  • Lee J; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.
  • Alsina-Fernandez J; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.
  • Fite NC; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.
  • Carrillo JJ; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, California 92121, United States.
  • Zhang FF; Lilly Biotechnology Center, Eli Lilly and Company, San Diego, California 92121, United States.
  • Chalmers MJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.
  • Dodge JA; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.
  • Broughton H; Centro de Investigación Lilly S.A., 28108-Alcobendas, Spain.
  • Espada A; Centro de Investigación Lilly S.A., 28108-Alcobendas, Spain.
ACS Med Chem Lett ; 9(9): 912-916, 2018 Sep 13.
Article em En | MEDLINE | ID: mdl-30258540
ABSTRACT
Molecular characterization of the binding epitope of IL-23R and its cognate cytokine IL-23 is paramount to understand the role in autoimmune diseases and to support the discovery of new inhibitors of this protein-protein interaction. Our results revealed that HDX-MS was able to identify the binding epitope of IL-23RIL-23, which opened the way to evaluate a peptide macrocycle described in the literature as disrupter of this autoimmune target. Thus, the characterization of the interactions of this chemotype by HDX-MS in combination with computational approaches was achieved. To our knowledge, this is the first reported structural evidence regarding the site where a small compound binds to IL-23R.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha